Research - Boston, Massachusetts, United States
VIC explores and develops new ways to modulate the immune system for therapeutic benefit. Our approach is deeply collaborative and involves leveraging the expertise and direct involvement of academic and industry scientists from US and abroad. We currently have nine products in our pipeline ranging from small molecule immune modulators for specific cancers through a vaccine in development for Q fever to a novel microencapsulant to enable allogeneic cell or tissue transplantation without immune suppression.
Outlook
WordPress.org
Google Font API
GoDaddy Hosting
Vimeo
Mobile Friendly